Skip to content
Trial Eligibility
Menu

Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging

NCT03581318

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Background: Magnetic resonance imaging (MRI) is an important non-invasive tool to study and diagnose cardiovascular disease. MRI scanners use strong magnetic fields and radio waves to create pictures of body organs. Researchers want to find better MRI methods and new ways of imaging cardiovascular disease and better understand normal and abnormal cardiovascular and brain function. Researchers are also interested in seeing if gadolinium, the commonly used MRI contrast agent, stays in the body long after the MRI was performed.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Normal and Abnormal Cardiovascular Physiology

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
7 to 100 years
Sex
All
Healthy volunteers
Accepted
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Last updated on ClinicalTrials.gov
October 5, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • National Institutes of Health Clinical Center · Bethesda, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.